共 50 条
Structural basis of Ac-SDKP hydrolysis by Angiotensin-I converting enzyme
被引:20
|作者:
Masuyer, Geoffrey
[1
]
Douglas, Ross G.
[2
,3
]
Sturrock, Edward D.
[2
,3
]
Acharya, K. Ravi
[1
]
机构:
[1] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England
[2] Univ Cape Town, Dept Integrat Biomed Sci, ZA-7935 Observatory, South Africa
[3] Univ Cape Town, Inst Infect Dis & Mol Med, ZA-7935 Observatory, South Africa
来源:
基金:
英国医学研究理事会;
新加坡国家研究基金会;
关键词:
ASPARTYL-LYSYL-PROLINE;
TERMINAL CATALYTIC DOMAIN;
2;
ACTIVE-SITES;
N-DOMAIN;
CRYSTAL-STRUCTURE;
KININASE-II;
INHIBITOR;
PEPTIDE;
FIBROSIS;
SPECIFICITY;
D O I:
10.1038/srep13742
中图分类号:
O [数理科学和化学];
P [天文学、地球科学];
Q [生物科学];
N [自然科学总论];
学科分类号:
07 ;
0710 ;
09 ;
摘要:
Angiotensin-I converting enzyme (ACE) is a zinc dipeptidylcarboxypeptidase with two active domains and plays a key role in the regulation of blood pressure and electrolyte homeostasis, making it the principal target in the treatment of cardiovascular disease. More recently, the tetrapetide N-acetylSer- Asp-Lys-Pro (Ac-SDKP) has emerged as a potent antifibrotic agent and negative regulator of haematopoietic stem cell differentiation which is processed exclusively by ACE. Here we provide a detailed biochemical and structural basis for the domain preference of Ac-SDKP. The high resolution crystal structures of N-domain ACE in complex with the dipeptide products of Ac-SDKP cleavage were obtained and offered a template to model the mechanism of substrate recognition of the enzyme. A comprehensive kinetic study of Ac-SDKP and domain co-operation was performed and indicated domain interactions affecting processing of the tetrapeptide substrate. Our results further illustrate the molecular basis for N-domain selectivity and should help design novel ACE inhibitors and Ac-SDKP analogues that could be used in the treatment of fibrosis disorders.
引用
收藏
页数:12
相关论文